Adjuvant aumolertinib in resected EGFR-mutated non-small cell lung cancer: A multiple-center real-world experience

被引：0
|
作者：
Zhang, Q. [1 ]
Ke, L. [1 ]
Huang, S. [2 ]
Yang, Y. [1 ]
He, T. [1 ]
Sun, H. [3 ]
Wu, Z. [1 ]
Zhang, X. [4 ]
Zhang, H. [5 ]
Lv, W. [1 ]
Hu, J. [1 ]
机构：
[1] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Thorac Surg, Hangzhou, Peoples R China
[2] Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Thorac Surg, Hangzhou, Peoples R China
[3] Zhejiang Univ, Taizhou Hosp, Dept Thorac Surg, Taizhou, Peoples R China
[4] Wenzhou Med Univ, Affiliated Hosp 1, Dept Thorac Surg, Wenzhou, Peoples R China
[5] Sci Grp Cent Med, Dept Med Oncol, Shanghai, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
98P
引用
收藏
页码：S98 / S98
页数：1
相关论文
共 50 条
  • [31] Resistance mechanisms to osimertinib in EGFR-mutated non-small cell lung cancer
    Alessandro Leonetti
    Sugandhi Sharma
    Roberta Minari
    Paola Perego
    Elisa Giovannetti
    Marcello Tiseo
    British Journal of Cancer, 2019, 121 : 725 - 737
  • [32] Managing Acquired Resistance in EGFR-Mutated Non-Small Cell Lung Cancer
    Forde, Patrick M.
    Ettinger, David S.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2015, 13 (08) : 528 - 532
  • [33] Leptomeningeal carcinomatosis from EGFR-mutated non-small cell lung cancer
    Iuchi, T.
    Shingyoji, M.
    Setoguchi, T.
    Yoshida, Y.
    Ashinuma, H.
    Hasegawa, Y.
    Sakaida, T.
    ANNALS OF ONCOLOGY, 2017, 28
  • [34] Critical points in the management of EGFR-mutated non-small cell lung cancer
    Casaluce, Francesca
    Gridelli, Cesare
    JOURNAL OF THORACIC DISEASE, 2022, 14 (06) : 1748 - 1752
  • [35] Resistance mechanisms to osimertinib in EGFR-mutated non-small cell lung cancer
    Leonetti, Alessandro
    Sharma, Sugandhi
    Minari, Roberta
    Perego, Paola
    Giovannetti, Elisa
    Tiseo, Marcello
    BRITISH JOURNAL OF CANCER, 2019, 121 (09) : 725 - 737
  • [36] Patient Characteristics, Testing and Treatment Patterns, and Outcomes in EGFR-Mutated Advanced Non-Small Cell Lung Cancer: A Multinational, Real-World Study
    Cliff Molife
    Katherine B. Winfree
    Hollie Bailey
    Yulia D’yachkova
    Cameron Forshaw
    Sangmi Kim
    Kaisa-Leena Taipale
    Tarun Puri
    Advances in Therapy, 2023, 40 : 3135 - 3168
  • [37] Patient Characteristics, Testing and Treatment Patterns, and Outcomes in EGFR-Mutated Advanced Non-Small Cell Lung Cancer: A Multinational, Real-World Study
    Molife, Cliff
    Winfree, Katherine B.
    Bailey, Hollie
    D'yachkova, Yulia
    Forshaw, Cameron
    Kim, Sangmi
    Taipale, Kaisa-Leena
    Puri, Tarun
    ADVANCES IN THERAPY, 2023, 40 (07) : 3135 - 3168
  • [38] Depression and Inflammation in Patients with EGFR-Mutated Non-Small Cell Lung Cancer
    Cardona, A.
    Arrieta, O.
    Rojas, L.
    Zatarain-Barron, Z.
    Ricaurte, L.
    Ruiz-Patino, A.
    Martin, C.
    Carranza, H.
    Vargas, C.
    Otero, J.
    Corrales, L.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S871 - S871
  • [39] NEUROLOGICAL EVOLUTION OF A PATIENT WITH EGFR-MUTATED NON-SMALL CELL LUNG CANCER
    Ianza, A.
    Dicorato, A.
    Guglielmi, A.
    Orlando, V.
    Furlanis, G.
    Curro, F.
    CHEST, 2022, 161 (06) : 333A - 333A
  • [40] Aumolertinib as adjuvant therapy in postoperative EGFR-mutated stage I-III non-small cell lung cancer with high-risk pathological factors
    Chen, X.
    He, J.
    Shen, H.
    Xi, Y.
    Chen, B.
    He, X.
    Gao, J.
    Yu, H.
    Shen, W.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (04) : S97 - S97
12345